Platelet-rich plasma vs corticosteroids for elbow epicondylitis: A systematic review and meta-analysis
Vol. 8 Iss. 3 | February 2020 | Number 11 Medicine (Baltimore). 2019 Dec;98(51):e18358Study Summary
7 randomized controlled trials were included in this meta-analysis comparing platelet-rich plasma (PRP) injections and corticosteroid injections for the treatment of lateral epicondylitis, or tennis elbow. Outcomes of interest included pain on a Visual Analog Scale (VAS), the MAYO index and Disability of the Arm, Shoulder and Hand (DASH) scores. Results revealed significantly favourable pooled DASH scores in the corticosteroid group at 8 weeks post-treatment. Pooled VAS pain scores and DASH scores at 24 weeks post-treatment were significantly in favour of the PRP group compared to the corticosteroid group. No significant differences in pooled MAYO index scores were observed between the two groups at any time-point.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
Are you affiliated with one of our partner associations?
Click here to gain complimentary access as part your association member benefits!
0 of 4 monthly FREE articles unlocked
